Wolf Theiss

The Relevance of EMIR for Non-Financial Actors

doing OTC business in non-regulated markets with volumes of more than EUR 1-3 billion gross notional value ▪ Implications of Regulation 648/2012 on OTC derivatives, central counterparties and trade repositories (EMIR) in selected CEE/SEE countries

This 2015 Wolf Theiss brochure, “THE RELEVANCE OF EMIR FOR NON-FINANCIAL ACTORS doing OTC business in non-regulated markets with volumes of more than EUR 1-3 billion gross notional value”, is intended as a practical guide to the general principles and features of the basic legislation and procedures with respect to the Regulation 648/2012 on OTC derivatives, central counterparties and trade repositories (EMIR) in the countries included in this publication.

While every effort has been made to ensure that this publication was accurate when finalised, it should be used only as a general reference guide and should not be relied upon as definitive for planning or making legal decisions. In these rapidly changing legal markets, the laws and regulations are frequently revised, either by amended legislation or by administrative interpretation.

For further information please contact

Peter
Daszkowski
Co-Managing Partner
Poland
Ronald B.
Given
Co-Managing Partner
Poland
Taras
Dumych
Partner
Ukraine
Markus
Heidinger
Partner
Austria
Katerina
Kraeva
Partner
Bulgaria
Anna
Rizova
Partner
Bulgaria
Katarína
Bieliková
Counsel
Slovak Republic
Claudia
Chiper
Counsel
Romania
Jan
Kotous
Counsel
Czech Republic
Gerhard
Dilger
Consultant
Austria
Melinda
Pelikán
Senior Associate
Hungary

Find a Lawyer

Top